[Bone marrow transfusions in hematopoietic aplasia].
D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000097:blood / Q000628:therapy; D000941:Antigens / Q000032:analysis; D001855:Bone Marrow Diseases / Q000532:radiotherapy / Q000628:therapy*; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D005260:Female; D005354:Fibrosarcoma / Q000097:blood / Q000628:therapy; D006386:Hemagglutination Tests; D006689:Hodgkin Disease / Q000097:blood / Q000628:therapy; D006801:Humans; D007018:Hypopituitarism / Q000097:blood / Q000628:therapy; D007223:Infant; D004915:Leukemia, Erythroblastic, Acute / Q000097:blood / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000628:therapy; D008297:Male; D013256:Steroids / Q000627:therapeutic use; D014184:Transplantation, Homologous; D014815:Vitamins / Q000627:therapeutic use
D000941:Antigens; D013256:Steroids; D014815:Vitamins
Unsere Erfahrungen mit Knochenmarktransfusionen bei Aplasie der Hämopoese.